ClinicalTrials.gov
public full text
Public Domain
Orlistat Treatment of Crigler-Najjar Disease
The purpose of this study was to determine whether orlistat is effective in decreasing plasma unconjugated bilirubin levels in patients with Crigler-Najjar disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency#883067
- Atazanavir/Ritonavir and Zinc Pharmacokinetic Study#843537
- A Study of Injectable BLB101 and Blincyto® in Adult Participants With R/R CD19+ B-ALL#846851
- Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma#886821
- Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067#834047
Record · ID 864656
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive